Nuveen’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $221K | Sell |
|
|||||
|
2023
Q4 | $904K | Buy |
|
|||||
|
2023
Q3 | $2.25M | Buy |
|
|||||
|
2023
Q2 | $1.29M | Sell |
|
|||||
|
2023
Q1 | $2.58M | Buy |
|
|||||
|
2022
Q4 | $2.28M | Buy |
|
|||||
|
2022
Q3 | $1.72M | Sell |
|
|||||
|
2022
Q2 | $3.02M | Buy |
|
|||||
|
2022
Q1 | $2.06M | Buy |
|
|||||
|
2021
Q4 | $1.91M | Sell |
|
|||||
|
2021
Q3 | $2.66M | Sell |
|
|||||
|
2021
Q2 | $2.08M | Sell |
|
|||||
|
2021
Q1 | $2.2M | Buy |
|
|||||
|
2020
Q4 | $2.4M | Buy |
|
|||||
|
2020
Q3 | $2.11M | Sell |
|
|||||
|
2020
Q2 | $2.43M | Buy |
|
|||||
|
2020
Q1 | $2.04M | Buy |
|
|||||
|
2019
Q4 | $2.6M | Sell |
|
|||||
|
2019
Q3 | $2.47M | Sell |
|
|||||
|
2019
Q2 | $2.45M | Buy |
|